UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 14, 2016
Accession Number:
0001144204-16-089634
Submission Type:
POS AM
CIK:
0001037649
Company Name:
INTERLEUKIN GENETICS INC
File Number:
333-189749